These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 26872669)

  • 21. Impact of aging immune system on neurodegeneration and potential immunotherapies.
    Liang Z; Zhao Y; Ruan L; Zhu L; Jin K; Zhuge Q; Su DM; Zhao Y
    Prog Neurobiol; 2017 Oct; 157():2-28. PubMed ID: 28782588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
    Brkic M; Balusu S; Libert C; Vandenbroucke RE
    Mediators Inflamm; 2015; 2015():620581. PubMed ID: 26538832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular pathways leading to neuronal dysfunction and degeneration.
    Kazantsev AG
    Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of regulatory T cells in neurodegenerative diseases.
    He F; Balling R
    Wiley Interdiscip Rev Syst Biol Med; 2013; 5(2):153-80. PubMed ID: 22899644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation in the nervous system--physiological and pathophysiological aspects.
    Schultzberg M; Lindberg C; Aronsson AF; Hjorth E; Spulber SD; Oprica M
    Physiol Behav; 2007 Sep; 92(1-2):121-8. PubMed ID: 17597167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The innate and adaptive immunological aspects in neurodegenerative diseases.
    Rodrigues MC; Sanberg PR; Cruz LE; Garbuzova-Davis S
    J Neuroimmunol; 2014 Apr; 269(1-2):1-8. PubMed ID: 24161471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases.
    Girolamo F; Coppola C; Ribatti D
    Brain Behav Immun; 2017 Oct; 65():68-89. PubMed ID: 28676349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogens, Neuroinflammation, and Neurodegeneration.
    Villa A; Vegeto E; Poletti A; Maggi A
    Endocr Rev; 2016 Aug; 37(4):372-402. PubMed ID: 27196727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases.
    Novellino F; Saccà V; Donato A; Zaffino P; Spadea MF; Vismara M; Arcidiacono B; Malara N; Presta I; Donato G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of microglia immunometabolism in neurodegeneration: Focus on molecular determinants and metabolic intermediates of metabolic reprogramming.
    Wang Q; Lu M; Zhu X; Gu X; Zhang T; Xia C; Yang L; Xu Y; Zhou M
    Biomed Pharmacother; 2022 Sep; 153():113412. PubMed ID: 36076537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Regulatory Role of IL-10 in Neurodegenerative Diseases.
    Porro C; Cianciulli A; Panaro MA
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32659950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune responses in neurodegenerative diseases.
    Shrestha R; Shakya Shrestha S; Millingtona O; Brewer J; Bushell T
    Kathmandu Univ Med J (KUMJ); 2014; 12(45):67-76. PubMed ID: 25219999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear receptors, inflammation, and neurodegenerative diseases.
    Saijo K; Crotti A; Glass CK
    Adv Immunol; 2010; 106():21-59. PubMed ID: 20728023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies.
    Bjelobaba I; Savic D; Lavrnja I
    Curr Pharm Des; 2017; 23(5):693-730. PubMed ID: 27981909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phagocytic clearance in neurodegeneration.
    Sokolowski JD; Mandell JW
    Am J Pathol; 2011 Apr; 178(4):1416-28. PubMed ID: 21435432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.
    Zipp F; Aktas O
    Trends Neurosci; 2006 Sep; 29(9):518-27. PubMed ID: 16879881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections).
    Ringheim GE; Conant K
    J Neuroimmunol; 2004 Feb; 147(1-2):43-9. PubMed ID: 14741426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic infections and inflammation affect chronic neurodegeneration.
    Perry VH; Cunningham C; Holmes C
    Nat Rev Immunol; 2007 Feb; 7(2):161-7. PubMed ID: 17220915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.